| Financial Year |
March 31 2023 |
| Monetary Funds |
2,375,152,352.20 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
8,424,980.99 |
| Accounts Receivable |
8,634,543,140.84 |
| Advances to Suppliers |
558,908,474.57 |
| Other Receivables |
426,378,917.15 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
223,747.65 |
| Inventories |
5,055,660,372.20 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
154,239,503.07 |
| Total Current Assets |
18,314,948,187.34 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
1,615,531,125.55 |
| Investment Properties |
13,391,671.22 |
| Fixed Assetes |
3,932,528,399.48 |
| Under-construction Projects |
913,273,558.34 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
2,250,237,369.24 |
| R&D expenses |
689,292,520.17 |
| Goodwill |
2,455,916,241.27 |
| Long-Term Deferred and Prepaid Expenses |
20,514,237.77 |
| Deferred Income Tax Assets |
153,369,860.61 |
| Other Non-Current Assets |
1,199,757,888.07 |
| Sub-Total of Non-Current Assets |
13,800,252,579.92 |
| Total Assets |
32,115,200,767.26 |
| Short-Term Loans |
563,013,919.12 |
| Trading Financial liabilities |
14,841,896.97 |
| Notes Payable |
1,360,474,461.93 |
| Accounts Payable |
4,990,423,949.03 |
| Accounts Received In Advance |
881,243.42 |
| Employee Compensation Payable |
175,666,718.25 |
| Taxes Payable |
479,789,639.50 |
| Interest Payable |
-- |
| Dividend Payable |
224,219.60 |
| Other payables |
2,684,871,969.84 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
140,795,971.83 |
| Other Current Liabilities |
24,158,784.99 |
| Sub-Total of Current Liabilities |
10,627,556,249.33 |
| Long-term Loans |
677,604,268.25 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
289,977,495.12 |
| Special Payable |
-- |
| Estimatied Liabilities |
39,859,049.95 |
| Deferred Income Tax Liabilities |
202,084,083.93 |
| Other Non-Current Liabilities |
73,251,500.00 |
| Sub-Total of Non-Current Liabilities |
1,567,111,480.78 |
| Total Liabilities |
12,194,667,730.11 |
| Paid-In Capital(Or Share Stock) |
1,753,995,348.00 |
| Capital Surplus |
2,387,821,545.06 |
| Surplus Reserve |
1,151,441,705.28 |
| LESS:Treasury Stock |
104,645,000.00 |
| Undistributed Profits |
14,245,364,208.58 |
| Minority Stockholder's Interest |
606,459,276.18 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
19,314,073,760.97 |
| Owner's Equity（Stockholder's Equity） |
19,920,533,037.15 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
32,115,200,767.26 |
